Enzychem Lifesciences (XKRX:183490) Short-Term Debt : ₩3,657 Mil (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Enzychem Lifesciences Short-Term Debt?

Enzychem Lifesciences's Short-Term Debt for the quarter that ended in Sep. 2024 was ₩3,657 Mil.

Enzychem Lifesciences's quarterly Short-Term Debt declined from Mar. 2024 (₩2,932 Mil) to Jun. 2024 (₩2,816 Mil) but then increased from Jun. 2024 (₩2,816 Mil) to Sep. 2024 (₩3,657 Mil).

Enzychem Lifesciences's annual Short-Term Debt declined from Dec. 2021 (₩48,496 Mil) to Dec. 2022 (₩36,242 Mil) and declined from Dec. 2022 (₩36,242 Mil) to Dec. 2023 (₩3,393 Mil).

Enzychem Lifesciences Short-Term Debt Historical Data

The historical data trend for Enzychem Lifesciences's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzychem Lifesciences Short-Term Debt Chart

Enzychem Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

2,614.00

5,438.40

48,495.78

36,241.80

3,393.32

Enzychem Lifesciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															4,008.80	3,393.32	2,931.66	2,816.39	3,656.64

Enzychem Lifesciences Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Enzychem Lifesciences Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Enzychem Lifesciences's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzychem Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzychem Lifesciences Corp (XKRX:183490) » Definitions » Short-Term Debt

Traded in Other Exchanges

N/A

Address

27 Gangnamdae-ro Seocho-gu, 10th Floor, aT Center, Seoul, KOR, 135-280

Website

http://www.enzychem.com

Enzychem Lifesciences Corp develops and produces APIs and functional health foods. It manufactures veterinary medicine tablets, capsules, syrups, injections, ointments, solutions for the diagnosis and prevention of various diseases. The company is also developing drugs to treat chemotherapy-induced neutropenia, chemo-radiation therapy-induced oral mucositis, asthma, psoriasis, rheumatoid arthritis, and others.

Enzychem Lifesciences Headlines

No Headlines